Anti-inflammatory activity is a possible mechanism by which the polyherbal formulation comprised of Nigella sativa (seeds), Hemidesmus indicus (root), and Smilax glabra (rhizome) mediates its antihepatocarcinogenic effects

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Galhena, Prasanna B ^a   Samarakoon, Sameera R ^b   Thabrew, M Ira ^b   Weerasinghe, G A K ^c   Thammitiyagodage, Mayuri G ^d   Ratnasooriya, W D ^b   Tennekoon, Kamani H ^b  

^a UNIVERSITY OF KELANIYA   (Sri Lanka)

^b UNIVERSITY OF COLOMBO   (Sri Lanka)

^c South Asian Institute of Technology and Medicine   (Sri Lanka)

^d Medical Research Institute Colombo   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CARRAGEENAN; DICLOFENAC; DIETHYLNITROSAMINE; HEMIDESMUS INDICUS EXTRACT; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERLEUKIN 6; MESSENGER RNA; NIGELLA SATIVA EXTRACT; NITRIC OXIDE; PLANT EXTRACT; SMILAX GLABRA EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG FORMULATION; DRUG MECHANISM; ENZYME ACTIVATION; ERYTHROCYTE MEMBRANE; HEMIDESMUS INDICUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE MIGRATION INHIBITION; LIVER CARCINOGENESIS; MALE; MEMBRANE STABILIZATION; MOUSE; NONHUMAN; NORMAL HUMAN; PAW EDEMA; PERITONEUM CELL; PLANT ROOT; PLANT SEED; PRIORITY JOURNAL; RAT; RHIZOME; SARSAPARILLA; SMILAX GLABRA;

EID: 84871423511     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/108626     Document Type: Article

References (61)

1. Grisham J. W., Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment. Carcinogenesis 1997 18 1 59 81 2-s2.0-0031428470 10.1093/carcin/18.1.59 (Pubitemid 28134618)
2. Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamura T., Nakanishi K., Fujimoto I., Inoue A., Yamazaki H., Kawashima T., Risk factors for hepatocellular carcinoma among patients with chronic liver disease. New England Journal of Medicine 1993 328 25 1797 1801 2-s2.0-0027243462 10.1056/NEJM199306243282501 (Pubitemid 23174709)
3. Nakamoto Y., Guidotti L. G., Kuhlen C. V., Fowler P., Chisari F. V., Immune pathogenesis of hepatocellular carcinoma. Journal of Experimental Medicine 1998 188 2 341 350 2-s2.0-0031872341 10.1084/jem.188.2.341 (Pubitemid 28357762)
4. Nakamoto Y., Kaneko S., Fan H., Momoi T., Tsutsui H., Nakanishi K., Kobayashi K., Suda T., Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-Fas ligand antibody therapy. Journal of Experimental Medicine 2002 196 8 1105 1111 2-s2.0-0037152184 10.1084/jem.20020633 (Pubitemid 35231769)
5. Hanahan D., Weinberg R. A., The hallmarks of cancer. Cell 2000 100 1 57 70 2-s2.0-0034614637 (Pubitemid 30046295)
6. Pan M. H., Chai G., Ho C. T., Food bioactives, apoptosis, and cancer. Molecular Nutrition & Food Research 2008 52 43 52 10.1002/mnfr.200700380 (Pubitemid 351211801)
7. Pikarsky E., Porat R. M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Uriell-Shoval S., Galun E., Ben-Neriah Y., NF- B functions as a tumour promoter in inflammation-associated cancer. Nature 2004 431 7007 461 466 2-s2.0-4644324186 10.1038/nature02924 (Pubitemid 39329586)
8. Sharma H. W., Narayanan R., The NF- B transcription factor in oncogenesis. Anticancer Research 1996 16 2 589 596 2-s2.0-0029666234
9. Waddick K. G., Uckun F. M., Innovative treatment programs against cancer: II. Nuclear factor- B (NF- B) as a molecular target. Biochemical Pharmacology 1999 57 1 9 17 2-s2.0-0032954699 10.1016/S0006-2952(98)00224-X (Pubitemid 29012491)
10. Chien-Fu H., Shih-Shen L., Pao-Hsin L., Young S. C., Yang C. C., The immunopharmaceutical effects and mechanisms of herb medicine. Cellular and Molecular Immunology 2008 5 1 23 31 2-s2.0-47049109646 10.1038/cmi.2008.3
11. Al-Naggar T. B., Gómez-Serranillos M. P., Carretero M. E., Villar A. M., Neuropharmacological activity of Nigella sativa L. extracts. Journal of Ethnopharmacology 2003 88 1 63 68 2-s2.0-0041666437 10.1016/S0378-8741(03)00157- 0 (Pubitemid 36945350)
12. Al-Ghamdi M. S., The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. Journal of Ethnopharmacology 2001 76 1 45 48 2-s2.0-0034987355 10.1016/S0378-8741(01)00216-1 (Pubitemid 32510729)
13. Vaidya K., Kukarni P. H., A study of an Ayurvedic formula viz, 'Jivak'. Deerghaya International 1991 7 20 222
14. Pharmacopoeia Commission of PRC, Pharmacopoeia of the People's Republic of China 2005 1 Beijing, China Chemical Industry Press
15. Iddamaldeniya S. S., Wickramasinghe N., Thabrew M. I., Ratnatunge N., Thammitiyagodage M. G., Protection against diethylnitrosoamine-induced hepatocarcinogenesis by an indigenous medicine comprised of Nigella sativa, Hemidesmus indicus and Smilax glabra: a preliminary study. Journal of Carcinogenesis 2003 2 1 6 12 2-s2.0-2942547469 10.1186/1477-3613-2-6 (Pubitemid 38751377)
16. Samarakoon S. R., Thabrew M. I., Galhena B. P., de Silva D., Tennekoon K., A comparison of the cytotoxic potential of standardized aqueous and ethanolic extracts of a polyherbal mixture comprised of Nigella sativa (seeds), Hemidesmus indicus (roots) and Smilax glabra (rhizome). Pharmacognosy Research 2010 2 6 335 342 2-s2.0-78951481966 10.4103/0974-8490.75451
17. Thabrew M. I., Mitry R. R., Morsy M. A., Hughes R. D., Cytotoxic effects of a decoction of Nigella sativa, Hemidesmus indicus and Smilax glabra on human hepatoma HepG2 cells. Life Sciences 2005 77 12 1319 1330 2-s2.0-21744456053 10.1016/j.lfs.2005.01.022 (Pubitemid 40943673)
18. Sabourdry M. A., Breeding and care of Laboratory animals. WHO document (WHO/LAB/881), vol. 1, 1988
19. Guidelines for ethics review of research proposals involving animals in Sri Lanka. Forum of Ethics Review Committee, 2009
20. Paget G. E., Barnes J. M., Evaluation of Drug Activities: Pharmacometrics 1964 New York, NY, USA Academic Press
21. Winter C. A., Risley E. A., Nuss G. W., Carrageenan-induced edema in the hind paw of rat as an assay for anti-inflammatory activity. Proceedings of the Society for Experimental Biology and Medicine 1962 111 544 547
22. Laupattarakasem P., Wangsrimongkol T., Surarit R., Hahnvajanawong C., In vitro and in vivo anti-inflammatory potential of Cryptolepis buchanani. Journal of Ethnopharmacology 2006 108 3 349 354 2-s2.0-33750631919 10.1016/j.jep.2006. 05.029 (Pubitemid 44693109)
23. Olajide O. A., Makinde J. M., Okpako D. T., Awe S. O., Studies on the anti-inflammatory and related pharmacological properties of the aqueous extract of Bridelia ferruginea stem bark. Journal of Ethnopharmacology 2000 71 1-2 153 160 2-s2.0-0033916981 10.1016/S0378-8741(99)00201-9 (Pubitemid 30440664)
24. Ito N., Tsuda H., Tatematsu M., Inoue T., Tagawa Y., Aoki T., Uwagawa S., Kagawa M., Ogiso T., Masui T., Imaida K., Fukushima S., Asamoto M., Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats-an approach for a new medium-term bioassay system. Carcinogenesis 1988 9 3 387 394 2-s2.0-0023858438 (Pubitemid 18067954)
25. Trnavsky K., Scherrer R. A., Whitehouse M. W., Drug effects on connective tissue metabolism. Anti-Inflammatory Agents 1974 2 New York, NY, USA Academic Press 303 326
26. Souza G. G. E. P., Ferreira S. H., Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity. Agents and Actions 1985 17 1 97 103 2-s2.0-0022351445 (Pubitemid 16179303)
27. Maccioni M., Cabezas L. E., Rivero V. E., Effect of prostatein, the major protein produced by the rat ventral prostate, on phagocytic cell functions. American Journal of Reproductive Immunology 2003 50 6 473 480 2-s2.0-0344898850 10.1046/j.8755-8920.2003.00110.x (Pubitemid 37483385)
28. Pereira Nacife V. P., Soeiro M. N. C., Gomes R. N., D'Avila H., Caire Castro-Faria Neto H., de Nazareth Leal Meirelles M., Morphological and biochemical characterization of macrophages activated by carrageenan and lipopolysaccharide in vivo. Cell Structure and Function 2004 29 2 27 34 2-s2.0-4444249162 10.1247/csf.29.27 (Pubitemid 39206717)
29. Olajide O. A., Makinde J. M., Okpako D. T., Awe S. O., Studies on the anti-inflammatory and related pharmacological properties of the aqueous extract of Bridelia ferruginea stem bark. Journal of Ethnopharmacology 2000 71 1-2 153 160 2-s2.0-0033916981 10.1016/S0378-8741(99)00201-9 (Pubitemid 30440664)
30. Perez R. M., Perez S., Zavala M. A., Salazar M., Anti-inflammatory activity of the bark of Hippocratea excelsa. Journal of Ethnopharmacology 1995 47 2 85 90 2-s2.0-0029030325 10.1016/0378-8741(95)01257-E
31. Balkwill F., Mantovani A., Inflammation and cancer: back to Virchow? The Lancet 2001 357 9255 539 545 2-s2.0-0035901090 10.1016/S0140-6736(00)04046-0 (Pubitemid 32173595)
32. Balkwill F., Charles K. A., Mantovani A., Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005 7 3 211 217 2-s2.0-17644394616 10.1016/j.ccr.2005.02.013 (Pubitemid 40568680)
33. Maccioni M., Cabezas L. E., Rivero V. E., Effect of prostatein, the major protein produced by the rat ventral prostate, on phagocytic cell functions. American Journal of Reproductive Immunology 2003 50 6 473 480 2-s2.0-0344898850 10.1046/j.8755-8920.2003.00110.x (Pubitemid 37483385)
34. Somnath N. M., Sandeep B. P., Nilophar S. N., Evaluation of anti-nociceptive and anti-inflammatory activity of stems of Gynandropsis pentaphylla Linn. International Journal of Green Pharmacy 2008 2 2 87 90 10.4103/0973-8258.41177
35. Warawanna B., Wisut W., Pornchai R., Synthetic curcumin inhibits carrageenan-induced paw edema in rats. Journal of Health Research 2009 23 11 16
36. Vinegar R., Scheirber W., Hugo R., Biphasic development of carageenin edema in rat. Journal of Pharmacology and Experimental Therapeutics 1969 166 96 103
37. Perianayagam J. B., Sharma S. K., Pillai K. K., Anti-inflammatory activity of Trichodesma indicum root extract in experimental animals. Journal of Ethnopharmacology 2006 104 3 410 414 2-s2.0-33644833093 10.1016/j.jep.2005.08. 077 (Pubitemid 43356654)
38. Kayagaki N., Yamaguchi N., Nakayama M., Hiroshi E., Okumura K., Yagita H., Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. Journal of Experimental Medicine 1999 189 9 1451 1460 2-s2.0-0033519303 10.1084/jem.189.9.1451 (Pubitemid 29227531)
39. Toyonaga T., Hino O., Sugai S., Wakasugi S., Abe K., Shichiri M., Yamamura-K. I., Chronic active hepatitis in transgenic mice expressing interferon- γ in the liver. Proceedings of the National Academy of Sciences of the United States of America 1994 91 2 614 618 2-s2.0-0028012009 (Pubitemid 24041452)
40. Mitsuru M., Yasunari N., Satoshi S., Kurata T., Kaneko S., Interferon- γ -mediated hepatocarcinogenesis in mice treated with diethylnitrosamine. Laboratory Investigation 2005 85 5 655 663 2-s2.0-18744376897 10.1038/labinvest.3700257 (Pubitemid 40675446)
41. Salem M. L., Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. International Immunopharmacology 2005 5 13-14 1749 1770 2-s2.0-27744476617 10.1016/j.intimp.2005.06.008 (Pubitemid 41594584)
42. Mahmood M. S., Gilani A. H., Khwaja A., Rashid A., Ashfaq M. K., The In vitro effect of aqueous extract of Nigella sativa seeds on nitric oxide production. Phytotherapy Research 2003 17 8 921 924 2-s2.0-0141626031 10.1002/ptr.1251 (Pubitemid 37152759)
43. Wang J., Zhao Y., Xu Q., Astilbin prevents concanavalin A-induced liver injury by reducing TNF- α production and T lymphocyte adhesion. Journal of Pharmacy and Pharmacology 2004 56 4 495 502 2-s2.0-1842471925 10.1211/0022357023033 (Pubitemid 38455615)
44. Yi H. W., Lu X. M., Fang F., Wang J., Xu Q., Astilbin inhibits the adhesion of T lymphocytes via decreasing TNF- α and its associated MMP-9 activity and CD44 expression. International Immunopharmacology 2008 8 10 1467 1474 2-s2.0-50949123494 10.1016/j.intimp.2008.06.006
45. Sayed A. A. R., Morcos M., Thymoquinone decreases AGE-induced NF- B activation in proximal tubular epithelial cells. Phytotherapy Research 2007 21 9 898 899 2-s2.0-34548619335 10.1002/ptr.2177 (Pubitemid 47401863)
46. El Gazzar M. A., El Mezayen R., Nicolls M. R., Dreskin S. C., Thymoquinone attenuates proinflammatory responses in lipopolysaccharide- activated mast cells by modulating NF-kappaB nuclear transactivation. Biochimica et Biophysica Acta 2007 1770 4 556 564 2-s2.0-33847104142 10.1016/j.bbagen. 2007.01.002 (Pubitemid 46281476)
47. Gandhidasan R., Thamaraichelvan A., Anti-inflammatory action of Lannea coromandelica by HRBC membrane stabilization. Fitoterapia 1991 62 1 81 83 2-s2.0-0025855395
48. David S., Studies force new view on biology of flavonoids. BioMed 2007 541 737 787
49. Jorge R. M., Leite J. P. V., Oliveira A. B., Evalaution of antinociceptive, anti-inflammatory and anti-ulcerogenic activities of Maytenus illicifolia. Journal of Ethnopharmacology 2004 94 1 93 100 10.1016/j.jep.2004. 04.019 (Pubitemid 38942839)
50. Palmer R. M. J., Ashton D. S., Moncada S., Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988 333 6174 664 666 2-s2.0-0023912670
51. Kim N. D., Kim E. M., Kang K. W., Cho M. K., Choi S. Y., Kim S. G., Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase. British Journal of Pharmacology 2003 140 4 661 670 2-s2.0-0242492625 10.1038/sj.bjp.0705490 (Pubitemid 37386430)
52. Miljkovic D., Trajkovic V., Inducible nitric oxide synthase activation by interleukin-17. Cytokine and Growth Factor Reviews 2004 15 1 21 32 2-s2.0-1642554789 10.1016/j.cytogfr.2003.10.003 (Pubitemid 38121288)
53. Sautebin L., Prostaglandins and nitric oxide as molecular targets for anti- inflammatory therapy. Fitoterapia 2000 71 1 S48 S57 2-s2.0-0034255098 10.1016/S0367-326X(00)00181-7 (Pubitemid 30621695)
54. Meade C. J., Turner G. A., Bateman P. E., The role of polyphosphoinositides and their breakdown products in A23187-induced release of arachidonic acid from rabbit polymorphonuclear leucocytes. Biochemical Journal 1986 238 2 425 436 2-s2.0-0022455495 (Pubitemid 16008515)
55. Sakaguchi Y., Shirahase H., Ichikawa A., Kanda M., Nozaki Y., Uehara Y., Effects of selective iNOS inhibition on type II collagen-induced arthritis in mice. Life Sciences 2004 75 19 2257 2267 2-s2.0-4444311945 10.1016/j.lfs.2004. 02.037 (Pubitemid 39180035)
56. Bradham C. A., Plümpe J., Manns M. P., Brenner D. A., Trautwein C., Mechanisms of hepatic toxicity: I. TNF-induced liver injury. American Journal of Physiology-Gastrointestinal and Liver Physiology 1998 275 3 G387 G392 2-s2.0-0031682110
57. Andy W., van Loo G., Heyninck K., Beyaert R., Hepatic tumor necrosis factor signaling and nuclear factor- B: effects on liver homeostasis and beyond. Endocrine Reviews 2007 28 4 365 386 2-s2.0-34250840799 10.1210/er.2006-0031 (Pubitemid 46984825)
58. Yamada Y., Webber E. M., Kirillova I., Peschon J. J., Fausto N., Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology 1998 28 4 I 959 970 2-s2.0-0031688717 10.1002/hep.510280410 (Pubitemid 28450256)
59. Hayden M. S., Ghosh S., Signaling to NF- B. Genes and Development 2004 18 18 2195 2224 2-s2.0-4444376712 10.1101/gad.1228704 (Pubitemid 39209568)
60. Pahl H. L., Activators and target genes of Rel/NF- B transcription factors. Oncogene 1999 18 49 6853 6866 2-s2.0-0033596121
61. Chandler N. M., Canete J. J., Callery M. P., Increased expression of NF- B subunits in human pancreatic cancer cells. Journal of Surgical Research 2004 118 1 9 14 2-s2.0-1842850737 10.1016/S0022-4804(03)00354-8 (Pubitemid 38490509)